bullish
WuXi AppTech IPO Preview: Pharmed Out
1.1k Views19 Nov 2018 06:57
WuXi AppTec Co Ltd (603259 CH) is a leading global pharmaceutical R&D outsourcing service provider and the largest in Asia by revenue in 2017....
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 9-minute read)
Discussions
(Paid Plans Only)
- Hujiang Ed. Tech - Just Say No to This IPO?27 Nov 2018
- Wuxi Apptec 药明康德 IPO: Welcome to the A/H Universe21 Nov 2018
- WuXi AppTech IPO Trading Update: What’s up with the Poor Cash Conversion?20 Nov 2018
- WuXi AppTech IPO Preview: Pharmed Out19 Nov 2018
- Innovent Biologics IPO Valuation: Surprisingly Grounded in Reality15 Oct 2018
- Innovent Biologics IPO Preview: Limited Upside on China's PD-1 Drug Market Compared to BeiGene02 Oct 2018
- Hua Medicine IPO Preview: Suffering from the Ascletis Over-Valuation Syndrome03 Sep 2018
x